Novel Effect of Antihelminthic Niclosamide on S100A4-Mediated Metastatic Progression in Colon CancerUlrike Sack, Ulrike Stein|JNCI Journal of the National Cancer Institute|2011Cited by 211
Epigenetic silencing of miR-520c leads to induced S100A4 expression and its mediated colorectal cancer progressionGiridhar Mudduluru, Ulrike Stein|Oncotarget|2017Cited by 55
The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasisDennis Kobelt, Ulrike Stein|Oncogene|2021Cited by 14
The importance of developing therapies targeting the biological spectrum of metastatic diseaseAndries Zijlstra, Julio A. Aguirre‐Ghiso, Dihua Yu et al.|Clinical & Experimental Metastasis|2019Cited by 13